Frédéric Desdouits is the founder of TreeFrog Therapeutics. TreeFrog Therapeutics has raised $83M in total funding. Latest round: Series B.
Frédéric Desdouits is a French biotech executive. He served as Chief Executive Officer of TreeFrog Therapeutics, a stem cell-derived cell therapy company. He led a $75 million Series B round in 2023. As of April 2026, Desdouits became Chief Executive Officer of Orano Med, a nuclear medicine company.
Full founder directory · Investor directory · Company funding database · Fundraising library